Susana Amorim - Gilde Healthcare


All team members
Susana Amorim
Senior Associate Healthtech
The Netherlands

Susana Amorim

Senior Associate - Healthtech

Susana Amorim joined Gilde in 2021 and focuses on the Healthtech sector. She is involved in deal sourcing, investment diligence, and portfolio management.

Prior to joining Gilde, Susana was a Biodesign Innovation fellow at Stanford University, a program that trains a select group of innovators to identify healthcare needs, invent new technologies, and implement products into patient care. Before this, Susana was also selected to participate in the MIT-Harvard Medical School Healthcare Innovation Bootcamp where she helped create a healthcare venture to improve mental health.

Susana began her career in structural heart, working as an Engineer and subsequently Project Manager at Xeltis, a clinical-stage start-up creating novel cardiovascular devices through regenerative medicine. She then worked as a Project Manager at Biotronik where she was responsible for and led the development of a new generation transcatheter aortic valve.

Susana has a Bachelor of Science and Master of Science in Biomedical Engineering from the University of Minho/University of Groningen. She also has a certification in project management (PMP) from the Project Management Institute.

She is a Portuguese citizen based in Gilde’s Utrecht office.

Pieter van der Meer

Managing Partner
Pieter van der Meer is founder and managing partner of Gilde Healthcare. Pieter joined Gilde in 1998 following a consultant position with KPMG Management Consulting. He is co-responsible for general management, the investment committees and...

Henry Zubaida

Investment Manager Healthtech
Henry Zubaida joined Gilde Healthcare in 2018 and focuses on the Healthtech sector. He has been involved in several investments including Big Health, Withings and Volta Medical. He is a board observer at FIRE1, Withings...

Sanne de Jongh

Investment Manager Therapeutics
Sanne de Jongh joined Gilde Healthcare in 2017 and focuses on the biopharmaceutical sector. She is involved in deal sourcing, assessment of investment cases and portfolio management. She represents Gilde on the board of Calypso...